Reviewer: Rugvedita Parakh, M.D. (see Reviewers page)
Revised: 9 February 2013, last major update June 2010
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.
● Rare poorly differentiated pleomorphic carcinoma that cannot be otherwise classified
● ICD-O: 8020/3
● Includes large cell undifferentiated carcinoma, but large cell neuroendocrine carcinoma, osteoclast-rich urothelial carcinoma and small cell carcinoma
are described separately
● Very rare if exclude other undifferentiated carcinomas with distinct histologic features indicated above
● Advanced stage at presentation with nodal metastases
● Poorer survival than urothelial carcinoma NOS of similar stage (Pathology 2010;42:364)
● Sheets of usually large polygonal or round cells with moderate to abundant cytoplasm, distinct cell borders
● Usually 90%+ of tumor is composed of large cell component
● Tumor is either infiltrative or has solid expansile nests with variable dyscohesive growth
● By definition, no features of other histologic types are present
● AE1/AE3 and CK7; variable CAM 5.2, CK20, thrombomodulin and uroplakin III
● High Ki-67, p53+
● AFP, beta hCG, PSA, vimentin, synaptophysin and chromogranin
morphology of lymphoma subtype, negative for keratin, positive for lymphocytic markers
● Melanoma: spindled or epithelioid; prominent nucleoli; positive for melanocytic markers
End of Bladder > Urothelial carcinoma-invasive > Undifferentiated carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).